Author:
Lima-Júnior Roberto César P.,Figueiredo Aline A.,Freitas Helano C.,Melo Maria Luisa P.,Wong Deysi Viviana T.,Leite Caio Abner V. G.,Medeiros Raul P.,Marques-Neto Raphael D.,Vale Mariana L.,Brito Gerly Anne C.,Oriá Reinaldo B.,Souza Marcellus H. L. P.,Cunha Fernando Q.,Ribeiro Ronaldo A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference55 articles.
1. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J et al (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100:2026–2046
2. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE et al (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820–831
3. Blijlevens N, Sonis S (2007) Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing hemotherapy- and radiotherapy-induced mucositis. Ann Oncol 18:817–826
4. Chester JD, Joel SP, Cheeseman SL, Hall GD, Braun MS, Perry J et al (2003) Phase I and pharmacokinetic study of intravenous irinotecan plus oral ciclosporin in patients with fluorouracil-refractory metastatic colon cancer. J Clin Oncol 21:1125–1132
5. Rocha-Lima CM, Green MR, Rotche R, Miller WH Jr, Jeffrey GM, Cisar LA et al (2004) Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate. J Clin Oncol 22:18–21
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献